ADA Advises Against Using Compounded GLP-1 RA Medications

In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of safety issues.
Medscape Medical News

source https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a1000m0u?src=rss